Affymetrix Inc.

The FDA has granted Affymetrix Inc. of Santa Clara, Calif., a producer of microarray technology for the analysis of genetic information, and Pathwork Diagnostics Inc. of Sunnyvale, Calif., an oncology-focused company, clearance for in vitro gene expression diagnostic testing. The microarray system examines and aids in the diagnosis of indistinguishable cancerous tumors to provide the best type of treatment for patients.





LATEST NEWS

• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024